Key result
Cardiometabolic medicine is emerging as a novel specialty requiring generalized training across multiple disciplines to manage obesity-induced multi-organ dysfunction and cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Highlights the emergence of cardiometabolic medicine as a novel specialty requiring generalized training across multiple disciplines to manage patients with obesity-induced multi-organ dysfunction.
Cardiometabolic medicine is centre stage currently as it integrates organ dysfunction in the pancreas, kidney, liver, and the heart induced by the pandemic of obesity leading to a high risk of heart failure with preserved or reduced ejection fraction, myocardial infarction, stroke, and pre-mature death. This novel specialty requires special, generalized training across several specialties in order to provide optimal care of the increasing number of patients with that condition.
No takes yet. Share an insight, caveat, or question.
T F Luescher (2025) conducted an editorial in Cardiometabolic disease. Cardiometabolic medicine is emerging as a novel specialty requiring generalized training across multiple disciplines to manage obesity-induced multi-organ dysfunction and cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: